This document summarizes cardiac physiology and considerations for anesthesia in cardiovascular diseases. It discusses cardiac reflexes like the baroreceptor reflex and effects of anesthetic agents. It notes that volatile anesthetics decrease heart rate and contractility by reducing calcium entry. For diseases like coronary artery disease, the goal is maintaining a favorable supply-demand relationship. For mitral stenosis, sinus rhythm and avoiding tachycardia are important. Congenital heart diseases require exclusion of air from IV fluids to prevent paradoxical embolism.
Coronary Artery Bypass Graft Under Cardiopulmonary BypassDharmraj Singh
This document discusses coronary artery bypass graft (CABG) surgery under cardiopulmonary bypass. It covers the preoperative evaluation, indications for CABG, intraoperative monitoring, cardiopulmonary bypass procedure, myocardial protection techniques, and considerations for weaning the patient off bypass.
Effects of anaesthetic agents on the cardiovascular systemaratimohan
The document discusses the cardiovascular effects of various anesthetic agents. It notes that volatile agents like halothane and enflurane cause decreases in blood pressure mainly through effects on myocardial contractility, while isoflurane, desflurane and sevoflurane lower blood pressure primarily by decreasing systemic vascular resistance. These agents also attenuate the baroreceptor reflex. Intravenous induction agents can cause an initial drop in blood pressure due to vasodilation, which is compensated for by an increase in heart rate, but may lead to hypotension in vulnerable patients. Barbiturates, benzodiazepines and other intravenous agents have varying effects depending on their class.
1. Mitral stenosis is most commonly caused by rheumatic fever and results in thickening and calcification of the mitral valve, reducing the valve orifice area and obstructing blood flow from the left atrium to ventricle.
2. The pathophysiology involves elevated left atrial pressure, pulmonary hypertension, and reduced cardiac output. Symptoms range from easy fatigability to pulmonary edema.
3. Physical exam findings include an opening snap, rumbling diastolic murmur, and signs of right heart failure in severe cases. Severity is graded based on orifice area, pulmonary artery pressure, and NYHA functional
This document defines cardiac failure and heart failure, describes the types and causes, and discusses the pathophysiology, clinical features, investigations, and treatment. Heart failure is a clinical syndrome where the heart cannot pump enough blood to meet the body's needs, or can only do so with elevated filling pressures. It can be systolic or diastolic in nature. Common causes include ischemic heart disease, cardiomyopathy, valvular disease, and hypertension. Symptoms include breathlessness, fatigue, and fluid retention. Echocardiography, biomarkers like BNP, and cardiac imaging are used in diagnosis and assessment. Treatment aims to relieve symptoms, improve quality of life, and reduce mortality through medications, device therapies, and lifestyle changes.
Cardiogenic shock is defined as inadequate tissue perfusion due to cardiac dysfunction or hypo-perfusion of end organs due to cardiac failure. It has a high mortality rate of 50-80% and is most commonly caused by extensive acute myocardial infarction. Symptoms include cyanosis, decreased consciousness, and low blood pressure. Diagnosis involves identifying hypotension, low cardiac index, and signs of hypoperfusion on physical exam along with supportive tests like EKG, echocardiogram, and Swan-Ganz catheter. Treatment focuses on optimizing prefusion with vasopressors or inotropes, diuretics, emergent revascularization through cardiac catheterization, and mechanical circulatory support like IABP,
Heart as a pump, heart failure & its treatmentChirantan MD
This document discusses cardiac physiology and heart failure. It begins by introducing the authors and location. It then discusses normal cardiac physiology parameters such as preload, afterload, heart rate, and ionotropic state. It explores these parameters in depth including how they are altered in heart failure. The document also examines factors that can lead to heart failure like cardiomyopathy or arrhythmias. In summary, it provides a comprehensive overview of cardiac function and the pathophysiology of heart failure.
Heart as a pump, heart failure & its treatmentChirantan MD
This document discusses cardiac physiology and heart failure. It begins by introducing the authors and location. It then discusses normal cardiac physiology parameters such as preload, afterload, heart rate, and ionotropic state. It explores these parameters in depth including how they are altered in heart failure. The document also examines factors that can lead to heart failure like cardiomyopathy or arrhythmias. In summary, it provides a comprehensive overview of cardiac function and the pathophysiology of heart failure.
The document discusses various types of cardiomyopathies including dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), and restrictive cardiomyopathy (RCM). It provides details on the definition, causes, symptoms, diagnostic criteria and treatment options for each type. DCM is the most common cardiomyopathy, usually caused by idiopathic or viral factors, leading to ventricular dilation and dysfunction. HCM is a genetic disease causing left ventricular hypertrophy that can lead to obstruction of blood flow. RCM involves restrictive filling of the ventricles with normal wall thickness.
Coronary Artery Bypass Graft Under Cardiopulmonary BypassDharmraj Singh
This document discusses coronary artery bypass graft (CABG) surgery under cardiopulmonary bypass. It covers the preoperative evaluation, indications for CABG, intraoperative monitoring, cardiopulmonary bypass procedure, myocardial protection techniques, and considerations for weaning the patient off bypass.
Effects of anaesthetic agents on the cardiovascular systemaratimohan
The document discusses the cardiovascular effects of various anesthetic agents. It notes that volatile agents like halothane and enflurane cause decreases in blood pressure mainly through effects on myocardial contractility, while isoflurane, desflurane and sevoflurane lower blood pressure primarily by decreasing systemic vascular resistance. These agents also attenuate the baroreceptor reflex. Intravenous induction agents can cause an initial drop in blood pressure due to vasodilation, which is compensated for by an increase in heart rate, but may lead to hypotension in vulnerable patients. Barbiturates, benzodiazepines and other intravenous agents have varying effects depending on their class.
1. Mitral stenosis is most commonly caused by rheumatic fever and results in thickening and calcification of the mitral valve, reducing the valve orifice area and obstructing blood flow from the left atrium to ventricle.
2. The pathophysiology involves elevated left atrial pressure, pulmonary hypertension, and reduced cardiac output. Symptoms range from easy fatigability to pulmonary edema.
3. Physical exam findings include an opening snap, rumbling diastolic murmur, and signs of right heart failure in severe cases. Severity is graded based on orifice area, pulmonary artery pressure, and NYHA functional
This document defines cardiac failure and heart failure, describes the types and causes, and discusses the pathophysiology, clinical features, investigations, and treatment. Heart failure is a clinical syndrome where the heart cannot pump enough blood to meet the body's needs, or can only do so with elevated filling pressures. It can be systolic or diastolic in nature. Common causes include ischemic heart disease, cardiomyopathy, valvular disease, and hypertension. Symptoms include breathlessness, fatigue, and fluid retention. Echocardiography, biomarkers like BNP, and cardiac imaging are used in diagnosis and assessment. Treatment aims to relieve symptoms, improve quality of life, and reduce mortality through medications, device therapies, and lifestyle changes.
Cardiogenic shock is defined as inadequate tissue perfusion due to cardiac dysfunction or hypo-perfusion of end organs due to cardiac failure. It has a high mortality rate of 50-80% and is most commonly caused by extensive acute myocardial infarction. Symptoms include cyanosis, decreased consciousness, and low blood pressure. Diagnosis involves identifying hypotension, low cardiac index, and signs of hypoperfusion on physical exam along with supportive tests like EKG, echocardiogram, and Swan-Ganz catheter. Treatment focuses on optimizing prefusion with vasopressors or inotropes, diuretics, emergent revascularization through cardiac catheterization, and mechanical circulatory support like IABP,
Heart as a pump, heart failure & its treatmentChirantan MD
This document discusses cardiac physiology and heart failure. It begins by introducing the authors and location. It then discusses normal cardiac physiology parameters such as preload, afterload, heart rate, and ionotropic state. It explores these parameters in depth including how they are altered in heart failure. The document also examines factors that can lead to heart failure like cardiomyopathy or arrhythmias. In summary, it provides a comprehensive overview of cardiac function and the pathophysiology of heart failure.
Heart as a pump, heart failure & its treatmentChirantan MD
This document discusses cardiac physiology and heart failure. It begins by introducing the authors and location. It then discusses normal cardiac physiology parameters such as preload, afterload, heart rate, and ionotropic state. It explores these parameters in depth including how they are altered in heart failure. The document also examines factors that can lead to heart failure like cardiomyopathy or arrhythmias. In summary, it provides a comprehensive overview of cardiac function and the pathophysiology of heart failure.
The document discusses various types of cardiomyopathies including dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), and restrictive cardiomyopathy (RCM). It provides details on the definition, causes, symptoms, diagnostic criteria and treatment options for each type. DCM is the most common cardiomyopathy, usually caused by idiopathic or viral factors, leading to ventricular dilation and dysfunction. HCM is a genetic disease causing left ventricular hypertrophy that can lead to obstruction of blood flow. RCM involves restrictive filling of the ventricles with normal wall thickness.
Cardiac reflexes involve afferent and efferent nerve pathways between the heart and central nervous system that help regulate cardiac function and homeostasis. Key reflexes discussed include the baroreceptor reflex, which helps maintain blood pressure, and the Bezold-Jarisch reflex, which causes hypotension, bradycardia, and coronary artery dilation in response to ventricular stimuli. Preventing or treating reflex cardiovascular changes during surgery may involve atropine, local anesthesia, lignocaine infusion, or adjusting anesthesia depth.
Cardiac tamponade occurs when fluid accumulates in the pericardial space, reducing cardiac filling and output. It can develop acutely or subacutely. Echocardiography is key for diagnosis, showing pericardial effusion, chamber collapse, and respiratory variations in flow velocities. Treatment involves drainage of fluid, usually by pericardiocentesis under ultrasound guidance. Subxiphoid approach carries liver/vessel injury risk but is safest in emergencies, while apical is easiest but risks heart wall puncture. Drainage resolves tamponade, and catheters are typically removed within 2 days if drainage is low.
This document discusses dilated cardiomyopathy (DCM), the most common type of cardiomyopathy. It provides details on:
1) The causes, symptoms, signs, diagnostic tests and goals of treatment for DCM. The mainstay of therapy includes vasodilators, digoxin and diuretics.
2) The morphological and microscopic features of DCM which involve enlargement and spherical dilation of the heart chambers.
3) Disease progression can lead to marked left ventricular dilatation and circulatory failure if left untreated. Management aims to relieve symptoms and slow progression.
Heart as a pump, heart failure & its treatmentChirantan MD
The document discusses normal cardiac physiology and heart failure. It describes how cardiac function depends on preload, afterload, heart rate, and ionotropic state. It then discusses the pathophysiology of systolic heart failure, including activation of neurohormonal systems and changes at the molecular level in contractile proteins and calcium homeostasis. Compensatory mechanisms in heart failure and the progression to decompensated heart failure are also summarized.
This document provides an overview of heart failure, including its pathophysiology, types, clinical presentation, investigations, and management. Heart failure occurs when the heart cannot pump enough blood to meet the body's needs and can develop due to conditions that weaken the heart such as heart attacks or high blood pressure. Symptoms depend on whether the left side, right side, or both sides of the heart are affected. Management involves treating the underlying cause, reducing symptoms through medications, lifestyle changes, and addressing complications.
This document summarizes the pathophysiology of heart failure (HF). It discusses how HF results from abnormalities in cardiac structure/function that limit oxygen delivery to tissues, despite normal filling pressures. The progression of HF is driven by neurohumoral activation of the sympathetic nervous system and renin-angiotensin-aldosterone system, which initially help compensate but eventually exacerbate cardiac remodeling and dysfunction. The document outlines the effects of various neurohormones involved in HF, including their normal and maladaptive roles in the progression of disease. Management of HF focuses on interrupting the harmful effects of long-term neurohumoral activation.
This document discusses the management of cyanotic patients. It covers several topics:
1. Causes of cyanosis including cardiac and non-cardiac causes such as lung diseases and neurological issues.
2. Evaluation of cyanotic newborns including detecting cyanosis and checking oxygen saturation levels.
3. Complications of cyanosis such as cyanotic spells, neurological complications, erythrocytosis, and anemia. Management of these complications is also discussed.
This document discusses cardiac arrhythmias. It covers the gross anatomy and physiology related to cardiac rhythm, classification of arrhythmias as bradydysrhythmias or tachydysrhythmias, and the mechanisms of arrhythmias including abnormal automaticity, triggered activity, and reentry. Etiologies of arrhythmias that are covered include electrolyte abnormalities, temperature changes, autonomic influences, acid-base imbalances, endocrine disorders, heart failure, and mechanical/electrical causes. Management of arrhythmias is also mentioned.
Heart failure occurs when the heart is unable to pump enough blood to meet the body's needs. It can be acute or chronic. Acute decompensated heart failure is a life-threatening condition characterized by increased filling pressures, pulmonary edema, reduced cardiac output, and organ dysfunction. Heart failure is determined by factors like contractility, heart rate, preload, and afterload. Preload refers to the stretch of heart muscle fibers before contraction and depends on factors like ventricular relaxation and compliance. Diastolic dysfunction can increase preload but also cause pulmonary congestion. Elevated natriuretic peptide levels help diagnose heart failure.
This document provides an overview of coronary artery disease, myocardial infarction, and related cardiac pharmacology. It discusses the etiology and risk factors of coronary artery disease, describes different types of angina pectoris, and outlines goals and medications for treating angina. It also covers atherosclerosis, statins, calcium channel blockers, beta blockers, ACE inhibitors, angiotensin receptor blockers, digoxin, and other cardiac medications. The document defines myocardial infarction and discusses gender differences, EKG changes, types, risks, effects, complications, diagnosis, and goals of treatment for MI.
Congestive heart failure can be caused by conditions that weaken the heart muscle or overload it. The main symptoms are shortness of breath, fatigue, cough, and fluid retention. Treatment focuses on correcting reversible causes, reducing fluid overload with diuretics, and inhibiting the renin-angiotensin-aldosterone system with ACE inhibitors. Other medications like beta blockers, digitalis, and vasodilators may also be used depending on the individual case. Monitoring through physical exams, labs, and imaging can help guide management and prevent exacerbations.
This document provides an overview of heart failure, including its causes, symptoms, and goals of treatment. It discusses the key physiological compensatory mechanisms in heart failure progression, including increased sympathetic nervous system activity, renin-angiotensin-aldosterone system activation, and myocardial hypertrophy. These compensations initially help the failing heart but ultimately lead to further deterioration. The document outlines pharmacologic interventions for heart failure, focusing on inhibitors of the renin-angiotensin-aldosterone system like angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, which reduce workload on the heart and improve outcomes.
This document defines and describes heart failure, its causes, forms, and pathophysiology. Heart failure is defined as the inability of the heart to pump enough blood to meet the body's needs. It is most often caused by impaired contractility from conditions like ischemic heart disease or cardiomyopathy. Heart failure can present as systolic or diastolic dysfunction and can affect the left or right ventricle. The body undergoes adaptive and maladaptive changes like neurohormonal activation to try to maintain cardiac output as heart function declines.
download link : https://www.dropbox.com/s/a8ug16pfkvv1bzp/Cardiorenal%20syndrome.ppt?m
Join us on our facebook group: NephroTube...............Follow our blog: www.nephrotube.blogspot.com
(5) nursing care plans (ncp) for cardiogenic shockMustafa Abdalla
The document provides information on cardiogenic shock, including its causes and nursing care plans. Cardiogenic shock is caused by the heart's inability to pump sufficiently due to impaired contractility. It is usually associated with conditions like myocardial infarction.
The nursing care plans for cardiogenic shock involve careful assessment, monitoring of vital signs and fluid status, and adjusting medications based on assessments. Five specific nursing care plans are outlined covering impaired gas exchange, decreased cardiac output, ineffective tissue perfusion, excess fluid volume, and anxiety. The plans describe potential signs and symptoms, desired outcomes, and nursing interventions with rationales.
Cardiogenic shock is caused by severe impairment of myocardial performance resulting in diminished cardiac output and end-organ hypoperfusion. It presents clinically as hypotension refractory to fluids with signs of poor tissue perfusion. Acute myocardial infarction accounts for most cases of cardiogenic shock. Rapid diagnosis and treatment is needed to prevent end-organ damage. Management involves hemodynamic support, revascularization when possible, and mechanical circulatory support for refractory cases.
Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)bkling
Your mindset is the way you make sense of the world around you. This lens influences the way you think, the way you feel, and how you might behave in certain situations. Let's talk about mindset myths that can get us into trouble and ways to cultivate a mindset to support your cancer survivorship in authentic ways. Let’s Talk About It!
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...The Lifesciences Magazine
Cold Sores, medically known as herpes labialis, are caused by the herpes simplex virus (HSV). HSV-1 is primarily responsible for cold sores, although HSV-2 can also contribute in some cases.
Cardiac reflexes involve afferent and efferent nerve pathways between the heart and central nervous system that help regulate cardiac function and homeostasis. Key reflexes discussed include the baroreceptor reflex, which helps maintain blood pressure, and the Bezold-Jarisch reflex, which causes hypotension, bradycardia, and coronary artery dilation in response to ventricular stimuli. Preventing or treating reflex cardiovascular changes during surgery may involve atropine, local anesthesia, lignocaine infusion, or adjusting anesthesia depth.
Cardiac tamponade occurs when fluid accumulates in the pericardial space, reducing cardiac filling and output. It can develop acutely or subacutely. Echocardiography is key for diagnosis, showing pericardial effusion, chamber collapse, and respiratory variations in flow velocities. Treatment involves drainage of fluid, usually by pericardiocentesis under ultrasound guidance. Subxiphoid approach carries liver/vessel injury risk but is safest in emergencies, while apical is easiest but risks heart wall puncture. Drainage resolves tamponade, and catheters are typically removed within 2 days if drainage is low.
This document discusses dilated cardiomyopathy (DCM), the most common type of cardiomyopathy. It provides details on:
1) The causes, symptoms, signs, diagnostic tests and goals of treatment for DCM. The mainstay of therapy includes vasodilators, digoxin and diuretics.
2) The morphological and microscopic features of DCM which involve enlargement and spherical dilation of the heart chambers.
3) Disease progression can lead to marked left ventricular dilatation and circulatory failure if left untreated. Management aims to relieve symptoms and slow progression.
Heart as a pump, heart failure & its treatmentChirantan MD
The document discusses normal cardiac physiology and heart failure. It describes how cardiac function depends on preload, afterload, heart rate, and ionotropic state. It then discusses the pathophysiology of systolic heart failure, including activation of neurohormonal systems and changes at the molecular level in contractile proteins and calcium homeostasis. Compensatory mechanisms in heart failure and the progression to decompensated heart failure are also summarized.
This document provides an overview of heart failure, including its pathophysiology, types, clinical presentation, investigations, and management. Heart failure occurs when the heart cannot pump enough blood to meet the body's needs and can develop due to conditions that weaken the heart such as heart attacks or high blood pressure. Symptoms depend on whether the left side, right side, or both sides of the heart are affected. Management involves treating the underlying cause, reducing symptoms through medications, lifestyle changes, and addressing complications.
This document summarizes the pathophysiology of heart failure (HF). It discusses how HF results from abnormalities in cardiac structure/function that limit oxygen delivery to tissues, despite normal filling pressures. The progression of HF is driven by neurohumoral activation of the sympathetic nervous system and renin-angiotensin-aldosterone system, which initially help compensate but eventually exacerbate cardiac remodeling and dysfunction. The document outlines the effects of various neurohormones involved in HF, including their normal and maladaptive roles in the progression of disease. Management of HF focuses on interrupting the harmful effects of long-term neurohumoral activation.
This document discusses the management of cyanotic patients. It covers several topics:
1. Causes of cyanosis including cardiac and non-cardiac causes such as lung diseases and neurological issues.
2. Evaluation of cyanotic newborns including detecting cyanosis and checking oxygen saturation levels.
3. Complications of cyanosis such as cyanotic spells, neurological complications, erythrocytosis, and anemia. Management of these complications is also discussed.
This document discusses cardiac arrhythmias. It covers the gross anatomy and physiology related to cardiac rhythm, classification of arrhythmias as bradydysrhythmias or tachydysrhythmias, and the mechanisms of arrhythmias including abnormal automaticity, triggered activity, and reentry. Etiologies of arrhythmias that are covered include electrolyte abnormalities, temperature changes, autonomic influences, acid-base imbalances, endocrine disorders, heart failure, and mechanical/electrical causes. Management of arrhythmias is also mentioned.
Heart failure occurs when the heart is unable to pump enough blood to meet the body's needs. It can be acute or chronic. Acute decompensated heart failure is a life-threatening condition characterized by increased filling pressures, pulmonary edema, reduced cardiac output, and organ dysfunction. Heart failure is determined by factors like contractility, heart rate, preload, and afterload. Preload refers to the stretch of heart muscle fibers before contraction and depends on factors like ventricular relaxation and compliance. Diastolic dysfunction can increase preload but also cause pulmonary congestion. Elevated natriuretic peptide levels help diagnose heart failure.
This document provides an overview of coronary artery disease, myocardial infarction, and related cardiac pharmacology. It discusses the etiology and risk factors of coronary artery disease, describes different types of angina pectoris, and outlines goals and medications for treating angina. It also covers atherosclerosis, statins, calcium channel blockers, beta blockers, ACE inhibitors, angiotensin receptor blockers, digoxin, and other cardiac medications. The document defines myocardial infarction and discusses gender differences, EKG changes, types, risks, effects, complications, diagnosis, and goals of treatment for MI.
Congestive heart failure can be caused by conditions that weaken the heart muscle or overload it. The main symptoms are shortness of breath, fatigue, cough, and fluid retention. Treatment focuses on correcting reversible causes, reducing fluid overload with diuretics, and inhibiting the renin-angiotensin-aldosterone system with ACE inhibitors. Other medications like beta blockers, digitalis, and vasodilators may also be used depending on the individual case. Monitoring through physical exams, labs, and imaging can help guide management and prevent exacerbations.
This document provides an overview of heart failure, including its causes, symptoms, and goals of treatment. It discusses the key physiological compensatory mechanisms in heart failure progression, including increased sympathetic nervous system activity, renin-angiotensin-aldosterone system activation, and myocardial hypertrophy. These compensations initially help the failing heart but ultimately lead to further deterioration. The document outlines pharmacologic interventions for heart failure, focusing on inhibitors of the renin-angiotensin-aldosterone system like angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, which reduce workload on the heart and improve outcomes.
This document defines and describes heart failure, its causes, forms, and pathophysiology. Heart failure is defined as the inability of the heart to pump enough blood to meet the body's needs. It is most often caused by impaired contractility from conditions like ischemic heart disease or cardiomyopathy. Heart failure can present as systolic or diastolic dysfunction and can affect the left or right ventricle. The body undergoes adaptive and maladaptive changes like neurohormonal activation to try to maintain cardiac output as heart function declines.
download link : https://www.dropbox.com/s/a8ug16pfkvv1bzp/Cardiorenal%20syndrome.ppt?m
Join us on our facebook group: NephroTube...............Follow our blog: www.nephrotube.blogspot.com
(5) nursing care plans (ncp) for cardiogenic shockMustafa Abdalla
The document provides information on cardiogenic shock, including its causes and nursing care plans. Cardiogenic shock is caused by the heart's inability to pump sufficiently due to impaired contractility. It is usually associated with conditions like myocardial infarction.
The nursing care plans for cardiogenic shock involve careful assessment, monitoring of vital signs and fluid status, and adjusting medications based on assessments. Five specific nursing care plans are outlined covering impaired gas exchange, decreased cardiac output, ineffective tissue perfusion, excess fluid volume, and anxiety. The plans describe potential signs and symptoms, desired outcomes, and nursing interventions with rationales.
Cardiogenic shock is caused by severe impairment of myocardial performance resulting in diminished cardiac output and end-organ hypoperfusion. It presents clinically as hypotension refractory to fluids with signs of poor tissue perfusion. Acute myocardial infarction accounts for most cases of cardiogenic shock. Rapid diagnosis and treatment is needed to prevent end-organ damage. Management involves hemodynamic support, revascularization when possible, and mechanical circulatory support for refractory cases.
Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)bkling
Your mindset is the way you make sense of the world around you. This lens influences the way you think, the way you feel, and how you might behave in certain situations. Let's talk about mindset myths that can get us into trouble and ways to cultivate a mindset to support your cancer survivorship in authentic ways. Let’s Talk About It!
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...The Lifesciences Magazine
Cold Sores, medically known as herpes labialis, are caused by the herpes simplex virus (HSV). HSV-1 is primarily responsible for cold sores, although HSV-2 can also contribute in some cases.
Hypertension and it's role of physiotherapy in it.Vishal kr Thakur
This particular slides consist of- what is hypertension,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is summary of hypertension -
Hypertension, also known as high blood pressure, is a serious medical condition that occurs when blood pressure in the body's arteries is consistently too high. Blood pressure is the force of blood pushing against the walls of blood vessels as the heart pumps it. Hypertension can increase the risk of heart disease, brain disease, kidney disease, and premature death.
Feeding plate for a newborn with Cleft Palate.pptxSatvikaPrasad
A feeding plate is a prosthetic device used for newborns with a cleft palate to assist in feeding and improve nutrition intake. From a prosthodontic perspective, this plate acts as a barrier between the oral and nasal cavities, facilitating effective sucking and swallowing by providing a more normal anatomical structure. It helps to prevent milk from entering the nasal passage, thereby reducing the risk of aspiration and enhancing the infant's ability to feed efficiently. The feeding plate also aids in the development of the oral muscles and can contribute to better growth and weight gain. Its custom fabrication and proper fitting by a prosthodontist are crucial for ensuring comfort and functionality, as well as for minimizing potential complications. Early intervention with a feeding plate can significantly improve the quality of life for both the infant and the parents.
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...rightmanforbloodline
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareVITASAuthor
This webinar helps clinicians understand the unique healthcare needs of the LGBTQ+ community, primarily in relation to end-of-life care. Topics include social and cultural background and challenges, healthcare disparities, advanced care planning, and strategies for reaching the community and improving quality of care.
Gemma Wean- Nutritional solution for Artemiasmuskaan0008
GEMMA Wean is a high end larval co-feeding and weaning diet aimed at Artemia optimisation and is fortified with a high level of proteins and phospholipids. GEMMA Wean provides the early weaned juveniles with dedicated fish nutrition and is an ideal follow on from GEMMA Micro or Artemia.
GEMMA Wean has an optimised nutritional balance and physical quality so that it flows more freely and spreads readily on the water surface. The balance of phospholipid classes to- gether with the production technology based on a low temperature extrusion process improve the physical aspect of the pellets while still retaining the high phospholipid content.
GEMMA Wean is available in 0.1mm, 0.2mm and 0.3mm. There is also a 0.5mm micro-pellet, GEMMA Wean Diamond, which covers the early nursery stage from post-weaning to pre-growing.
This particular slides consist of- what is hypotension,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is the summary of hypotension:
Hypotension, or low blood pressure, is when the pressure of blood circulating in the body is lower than normal or expected. It's only a problem if it negatively impacts the body and causes symptoms. Normal blood pressure is usually between 90/60 mmHg and 120/80 mmHg, but pressures below 90/60 are generally considered hypotensive.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Michigan HealthTech Market Map 2024. Includes 7 categories: Policy Makers, Academic Innovation Centers, Digital Health Providers, Healthcare Providers, Payers / Insurance, Device Companies, Life Science Companies, Innovation Accelerators. Developed by the Michigan-Israel Business Accelerator
Unlocking the Secrets to Safe Patient Handling.pdfLift Ability
Furthermore, the time constraints and workload in healthcare settings can make it challenging for caregivers to prioritise safe patient handling Australia practices, leading to shortcuts and increased risks.
About this webinar: This talk will introduce what cancer rehabilitation is, where it fits into the cancer trajectory, and who can benefit from it. In addition, the current landscape of cancer rehabilitation in Canada will be discussed and the need for advocacy to increase access to this essential component of cancer care.
MBC Support Group for Black Women – Insights in Genetic Testing.pdfbkling
Christina Spears, breast cancer genetic counselor at the Ohio State University Comprehensive Cancer Center, joined us for the MBC Support Group for Black Women to discuss the importance of genetic testing in communities of color and answer pressing questions.
4. Baroreceptor reflex
Maintains BP around a preset value
through a negative feedback loop
Changes in BP are monitored by
circumferential and longitudinal stretch
receptors in carotid sinus and aortic
arch
Stretch receptors afferents of
glossopharyngeal and vagus
nucleus solitarius in cardiovascular
centre of medulla
5.
6. Stretch receptors activated at BP >
170mm Hg
Response includes decrease in cardiac
contractility, heart rate and vascular tone
Activation of parasympathetic system
decreases HR and myocardial
contractility
7. Important during acute blood loss and
shock
Reflex arch loses functional capacity at
BP< 50 mm Hg
Volatile anaesthetics (particularly
halothane) decrease the HR component
of this reflex
8. Concomitant use of CCBs, ACE
inhibitors or PDE inhibitors decreases
the cardiovascular response of raising
BP
Pts with chronic HTN often exhibit
perioperative cardiac instability due to
their decreased baroreceptor reflex
response
9. CHEMORECEPTOR
REFLEX
Chemosensitive cells located in
carotid bodies and aortic body
Respond to changes in pH and PO2
Afferents: Sinus nv of Hering (br of
glossopharyngeal) and vagus
Centre: chemosensitive area of
medulla
Effects: 1. stimulates resp system 2.
increase ventilatory drive 3. reduction
in HR and myocardial contractility
10.
11.
12. BAINBRIDGE REFLEX
Elicited by stretch receptors located in
Rt atrial wall and cavoatrial junction
Increase in Rt sided filling pressure
sends vagal afferent signal to
cardiovascular centre in medulla
inhibiting parasympathetic activity
causing increase in HR
13.
14. BEZOLD- JARISCH REFLEX
Triggers: myocardial
ischemia/infarction, thrombolysis,
revascularisation and syncope
This reflex responds to noxious stimuli
sensed by chemo and mechano
receptors within LV wall resulting in
hypotension, bradycardia and
coronary art dilatation
Cardioprotective reflex
15.
16. VALSALVA MANEUVER
Forced expiration against a closed
glottis increases intrathoracic
pressure, increased CVP and
decreased venous return
Cardiac output and BP are decreased
after this maneuver
This is sensed by baroreceptors
resulting in sympathetic stimulation
causing increase in HR and
myocardial contractility
17.
18. CUSHING REFLEX
Occurs as a result of cerebral
ischemia caused by raised ICP
Activates sympathetic system causing
rise in HR, BP and myocardial
contractility to improve cerebral
perfusion
As a result of high vascular tone reflex
bradycardia mediated by baro
receptors will ensue
19.
20. OCULOCARDIAC REFLEX
Provoked by pressure applied to globe
of eye or traction on surrounding
tissues
Stretch receptors in extraocular
muscles send afferent signals through
short and long ciliary nvs
Ciliary nvs merge with trigeminal nv at
ciliary ganglion. Impulses carried to
gasserian ganglion resulting in
increased parasympathetic tone and
21.
22. EFFECTS OF ANAESTHETIC
AGENTS ON
CARDIOVASCULAR SYSTEM
Adrenergic agonists enhance the rate
of relaxation by enhancing calcium
reuptake by the Sarcoplasmic
reticulum
Release of ACh following vagal
stimulation depresses contractility
through increased cGMP and
23. Acidosis blocks slow calcium channels
and therefore also depresses cardiac
contractility by unfavourably altering
intracellular calcium kinetics
24. • Volatile anaesthetics depress cardiac
contractility by decreasing calcium
entry into cells during depolarization
• This blockade is potentiated by
hypocalcemia, ß-adrenergic blockade
and calcium channel blockers
25.
26. Potent inhaled anaesthetics decrease
SA node automacity
Modest direct effects on AV node,
prolonging conduction times and
increasing refractoriness
Explains junctional tachycardias when
an anticholinergic is administered for
sinus bradycardia during inhalation
anaesthesia
27. Mechanism of cardiac depression by
IV anaesthetics is not well established
Ketamine has the least depressant
effect on cardiac contractility
Local anaesthetics also depress
cardiac contractility by reducing
calcium influx and release in dose-
dependant fashion
28. Opioids, particularly fentanyl and
sufentanyl can depress cardiac
conduction, increasing AV node
conduction and the refractory period
and prolonging the duration of
Purkinje fibre action potential
29. Lignocaine, due to its
electrophysiological effects, in low
doses can be therapeutic
However, at high blood
concentrations, it depresses
conduction by binding to sodium
channels and at extremely high
concentrations it also depresses the
SA node
30. Bupivacaine binds open or inactivated
sodium channels and dissociates from
them slowly.
It can cause profound sinus
bradycardia and sinus node arrest and
malignant ventricular arrhythmias. It
can also depress left ventricular
contractility
31. ANAESTHETIC
CONSIDERATIONS
Cardiovascular complications account
for 25-50% deaths following non
cardiac surgeries
Perioperative MI, pulmonary edema,
CHF, arrhythmias, and
thromboembolism are most commonly
seen in patients with preexisting
cardiovascular disease
32. Holter monitoring, exercise ECG,
myocardial perfusion scans and 2D
ECHO are important in determining
pre op risk and the need for coronary
angiography
Patients with extensive ( three-vessel
or left main) coronary artery disease, a
history of MI or ventricular dysfunction
are at greatest risk of cardiac
complications
33. Regardless of the level of pre op BP
control many pts with HTN display an
accentuated hypotensive response to
induction of anaesthesia followed by
an exaggerated hypertensive
response to intubation
These pts display an exaggerated
response to both endogenous
catecholamines(intubation or surgical
stimulus) and exogenously
administered sympathetic agonists
34. Sudden withdrawal of antianginal
medication preop- particularly ß
blockers- can precipitate sudden,
rebound increase in ischaemic
episodes
35. Priority in managing ischaemic heart
disease is maintaining a favourable
myocardial supply- demand
relationship
Autonomic- mediated increases in
heart rate and BP should be controlled
by deep anaesthesia or adrenergic
blockade and excessive reductions in
coronary perfusion pressure or arterial
oxygen content are to be avoided
36. Intra op detection of ischaemia:
1. Recognition of ECG changes
2. Hemodynamic manifestations
3. Regional wall motion anomalies on
TEE
37. MITRAL STENOSIS
Principal goal is maintainence of sinus
rhythm (if present preop) and to avoid
tachycardia, large increases in cardiac
output and both hypovolemia and fluid
overload by judicious administration of
IV fluids
38. MITRAL REGURGITATION
Tailored to severity of regurgitation and
to underlying left ventricular function
Exacerbating factors such as slow heart
rate and acute increases in afterload
should be avoided
Excessive volume expansion can also
worsen regurgitation by dilating LV
39. AORTIC STENOSIS
Maintainence of normal sinus rhythm,
heart rate, vascular resistance and
intravascular volume are critical
Loss of normally timed atrial systole
often leads to rapid deterioration
particularly when associated with
tachycardia
Spinal and epidural anaes are relatively
contraindicated in severe AS
40. AORTIC REGURGITATION
Bradycardia and increase in SVR
increase regurgitant volume in pts with
AR whereas tachycardia can contribute
to myocardial ischaemia
Compensatory increase in preload
should be maintained but excessive
fluid replacement may lead to
pulmonary edema
41. CONGENITAL HEART DISEASE
Presence of shunt flow between right
and left hearts, regardless of direction,
mandates the meticulous exclusion of
air bubbles or particulate matter from IV
fluids to prevent paradoxical embolism
into cerebral or coronary circulations
42. Goal in management of TOF should
be to maintain intravascular volume
and SVR
Increase in PVR, such as might occur
from acidosis or excessive airway
pressure should be avoided
Right-to-left shunting tends to slow the
uptake of inhalational anaesthetics; in
contrast, it may accelerate the onset
of IV anaesthetics